BATF3 programs CD8+ T cell memory-Reference-Cited by-同舟云学术

BATF3 programs CD8+ T cell memory

Published:2020-09-28 Issue:11 Volume:21 Page:1397-1407
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Ataide Marco A.^ORCID,Komander Karl,Knöpper Konrad^ORCID,Peters Annika E.,Wu Hao,Eickhoff Sarah,Gogishvili Tea,Weber Justus^ORCID,Grafen Anika,Kallies Axel^ORCID,Garbi Natalio,Einsele Hermann^ORCID,Hudecek Michael^ORCID,Gasteiger Georg,Hölzel Michael,Vaeth Martin,Kastenmüller Wolfgang^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

https://www.nature.com/articles/s41590-020-0786-2.pdf

Reference52 articles.

1. Kaech, S. M. & Cui, W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12, 749–761 (2012).

2. Bedoui, S., Heath, W. R. & Mueller, S. N. CD4+ T-cell help amplifies innate signals for primary CD8+ T-cell immunity. Immunol. Rev. 272, 52–64 (2016).

3. Eickhoff, S. et al. Robust anti-viral immunity requires multiple distinct T cell–dendritic cell interactions. Cell 162, 1322–1337 (2015).

4. Hor, J. L. et al. Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection. Immunity 43, 554–565 (2015).

5. Shaulian, E. & Karin, M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131–E136 (2002).

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-744-5p promotes T-cell differentiation via inhibiting STK11;Gene;2024-10

2. TCF-1 and TOX regulate the memory formation of intestinal group 2 innate lymphoid cells in asthma;Nature Communications;2024-09-08

3. Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity;Nature Immunology;2024-08-28

4. Profound T Lymphocyte and DNA Repair Defect Characterizes Schimke Immuno-Osseous Dysplasia;Journal of Clinical Immunology;2024-08-17

5. Chimäre Antigenrezeptor-T-Zellen – Die Evolution zellulärer Immuntherapie von malignen zu nicht-malignen Erkrankungen;Aktuelle Rheumatologie;2024-08